Learn about the innovative method to create aptamers that could revolutionise treatments for infectious diseases.

Explore the potential of protein design with the new deep learning approach from Chongqing University to enhance binding ...

While ADCs continue to attract attention in oncology, many developers remain focused on antibodies – overlooking the critical role of payload design. At Sygnature Discovery, Dr Joshua Greally is ...

Learn how radiopharmaceuticals are transforming nuclear medicine and cancer therapy through targeted diagnostics and ...

Forget the buzzwords – SLAS 2025 showed what’s genuinely driving progress in drug discovery: usable AI, collaborative platforms and tools that solve real problems. This year, the focus wasn’t on bold ...

Cytokine release syndrome (CRS) is a major barrier in cancer immunotherapy – but what if we could prevent it before it begins? Dr Liam Tremble, Principal Scientist at Poolbeg Pharma, discusses how ...

Researchers have developed the first fully stem cell-derived model of human ovarian organoids, or “ovaroids,” offering a powerful new tool for studying infertility, differences in sex development ...

Tyra Biosciences has announced new data showing that its investigational therapy, TYRA-300, improves bone growth and corrects skeletal abnormalities in preclinical models of achondroplasia and ...

ELRIG has announced the keynote speakers for Drug Discovery 2025, its flagship life sciences event taking place in Liverpool, England this October. As a volunteer-led, not-for-profit organisation, ...

Vitalant is transforming the path from preclinical drug discovery to patient care by enabling access to cutting-edge cell and gene therapies. With decades of expertise and a nationwide network, find ...

Scenic Biotech and Stanford University have published a study identifying PLA2G15 as a new drug target in neurodegenerative and metabolic diseases, potentially enabling future treatments for ...